DNX - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
86372931
Word Mark
DNX
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2016-06-06
Filing Date
2014-08-21
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260117, 260121 - Two concentric circles. Circles that are totally or partially shaded.
Published for Opposition Date
2015-02-17
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
COGAN, BRITTNEY LORRAI
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the letters "DNX" in upper-case stylized font; an outline of a circle appears in the center of the letter "X".
Goods and Services
Drug delivery agents in the form of conjugated molecules, gene sequences, peptides, proteins, polysaccharides and polymers that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical products for the treatment
Goods and Services
Drug delivery agents in the form of conjugated molecules, gene sequences, etc. that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-12-30
Primary Code
005
First Use Anywhere Date
2013-01-00
First Use In Commerce Date
2015-07-13
Correspondences
Name
J. Mark Dickison
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2014-09-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2014-09-05 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2014-12-07 | ASSIGNED TO EXAMINER |
| 2014-12-08 | NON-FINAL ACTION WRITTEN |
| 2014-12-08 | NON-FINAL ACTION E-MAILED |
| 2014-12-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2014-12-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2014-12-17 | UNDELIVERABLE MAIL - COURTESY COPY MAILED |
| 2014-12-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2014-12-30 | ASSIGNED TO LIE |
| 2014-12-30 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2014-12-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2015-01-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2015-01-15 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2015-01-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2015-02-17 | PUBLISHED FOR OPPOSITION |
| 2015-02-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2015-04-14 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2015-04-20 | TEAS STATEMENT OF USE RECEIVED |
| 2015-05-20 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2015-04-20 | USE AMENDMENT FILED |
| 2015-05-20 | STATEMENT OF USE PROCESSING COMPLETE |
| 2015-05-20 | SU - NON-FINAL ACTION - WRITTEN |
| 2015-05-20 | NON-FINAL ACTION E-MAILED |
| 2015-05-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2015-05-27 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2015-06-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2015-06-03 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2015-06-03 | SU - NON-FINAL ACTION - WRITTEN |
| 2015-06-03 | NON-FINAL ACTION E-MAILED |
| 2015-06-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2015-10-31 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2015-11-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2015-11-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2015-11-09 | SU - NON-FINAL ACTION - WRITTEN |
| 2015-11-09 | NON-FINAL ACTION E-MAILED |
| 2015-11-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2016-04-15 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED |
| 2016-04-15 | ATTORNEY REVOKED AND/OR APPOINTED |
| 2016-06-06 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2016-06-06 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
